It has been found that the Erk1/2 and SRC signaling pathways regulate the CD133 expression, and CD133 can modulate the epithelial-to-mesenchymal transition in pancreatic cancer cells [10]. This evidence concerns the gene PROM1 and pancreatic neoplasm.